FI933853A - Farmaceutiska kompositioner, som innehaoller antracyklingslykosider kopplade till ett polymerderivat, och foerfarande foer deras framstaellning - Google Patents

Farmaceutiska kompositioner, som innehaoller antracyklingslykosider kopplade till ett polymerderivat, och foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI933853A
FI933853A FI933853A FI933853A FI933853A FI 933853 A FI933853 A FI 933853A FI 933853 A FI933853 A FI 933853A FI 933853 A FI933853 A FI 933853A FI 933853 A FI933853 A FI 933853A
Authority
FI
Finland
Prior art keywords
polymerderivat
kopplade
antracyklingslykosider
pharmaceutical composition
foerfarande foer
Prior art date
Application number
FI933853A
Other languages
English (en)
Other versions
FI933853A0 (fi
Inventor
Marco Adami
Roberto Magrini
Paolo Maranghi
Antonino Suarato
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI933853A0 publication Critical patent/FI933853A0/fi
Publication of FI933853A publication Critical patent/FI933853A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI933853A 1992-01-07 1993-09-03 Farmaceutiska kompositioner, som innehaoller antracyklingslykosider kopplade till ett polymerderivat, och foerfarande foer deras framstaellning FI933853A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200247A GB9200247D0 (en) 1992-01-07 1992-01-07 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
PCT/EP1992/002968 WO1993013804A1 (en) 1992-01-07 1992-12-21 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation

Publications (2)

Publication Number Publication Date
FI933853A0 FI933853A0 (fi) 1993-09-03
FI933853A true FI933853A (fi) 1993-09-03

Family

ID=10708214

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933853A FI933853A (fi) 1992-01-07 1993-09-03 Farmaceutiska kompositioner, som innehaoller antracyklingslykosider kopplade till ett polymerderivat, och foerfarande foer deras framstaellning

Country Status (22)

Country Link
US (1) US6245358B1 (fi)
EP (1) EP0574571B1 (fi)
JP (1) JPH06505755A (fi)
KR (1) KR100290222B1 (fi)
AT (1) ATE179618T1 (fi)
AU (1) AU666513B2 (fi)
CA (1) CA2105466A1 (fi)
DE (1) DE69229109T2 (fi)
DK (1) DK0574571T3 (fi)
ES (1) ES2133380T3 (fi)
FI (1) FI933853A (fi)
GB (1) GB9200247D0 (fi)
GR (1) GR3030633T3 (fi)
HU (2) HU217806B (fi)
IL (1) IL104256A (fi)
MX (1) MX9207605A (fi)
NZ (1) NZ246577A (fi)
RU (1) RU2118171C1 (fi)
TW (1) TW218847B (fi)
UA (1) UA32522C2 (fi)
WO (1) WO1993013804A1 (fi)
ZA (1) ZA9210049B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
US5965118A (en) * 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds
WO1998047496A2 (en) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc. Polymer-platinum compounds
US7314956B2 (en) 2001-08-08 2008-01-01 Vaxim, Inc. Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
WO2003017938A2 (en) * 2001-08-22 2003-03-06 Watson Pharmaceuticals, Inc. Conjugates targeted to target receptors
US20030125268A1 (en) * 2002-08-28 2003-07-03 Rybak Mary Ellen Margaret Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
JP2006505579A (ja) * 2002-10-25 2006-02-16 ファイザー・プロダクツ・インク 懸濁形態でのアリール複素環活性薬物の蓄積製剤
ES2606464T3 (es) * 2003-01-14 2017-03-24 Yeda Research And Development Co. Formulaciones parenterales de péptidos para el tratamiento del lupus eritematoso sistémico
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
US20100160442A1 (en) * 2006-07-18 2010-06-24 Ossovskaya Valeria S Formulations for cancer treatment
RS52633B (en) * 2007-01-16 2013-06-28 Bipar Sciences Inc. CANCER TREATMENT FORMULATION
BRPI0820198A2 (pt) * 2007-11-12 2019-09-24 Novartis Ag composições farmacêuticas
WO2009118754A2 (en) * 2008-03-28 2009-10-01 Astron Research Limited A process for preparing a stable lyophilized composition
WO2009133545A2 (en) * 2008-04-30 2009-11-05 Ben Gurion University Of The Negev Research And Development Authority Vascular delivery systems
KR102239752B1 (ko) * 2019-12-11 2021-04-13 한국과학기술연구원 종양 특이적 약물복합체와 항pd-l1 항체를 유효성분으로 하는 암 예방 또는 치료를 위한 병용 투여용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (fi) * 1974-04-23 1977-03-31
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
FR2583983B1 (fr) * 1985-06-07 1988-05-27 Centre Nat Rech Scient Nouvelles prodrogues macromoleculaires hydrosolubles, leur preparation et leur utilisation comme medicaments notamment antitumoraux et antiparasitaires
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US4968742A (en) * 1987-11-09 1990-11-06 Miles Inc. Preparation of ligand-polymer conjugate having a controlled number of introduced ligands
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

Also Published As

Publication number Publication date
ATE179618T1 (de) 1999-05-15
RU2118171C1 (ru) 1998-08-27
JPH06505755A (ja) 1994-06-30
IL104256A0 (en) 1993-05-13
UA32522C2 (uk) 2001-02-15
ZA9210049B (en) 1993-10-06
US6245358B1 (en) 2001-06-12
AU3346893A (en) 1993-08-03
IL104256A (en) 1997-02-18
EP0574571A1 (en) 1993-12-22
DE69229109T2 (de) 1999-08-26
FI933853A0 (fi) 1993-09-03
AU666513B2 (en) 1996-02-15
GR3030633T3 (en) 1999-10-29
ES2133380T3 (es) 1999-09-16
GB9200247D0 (en) 1992-02-26
DE69229109D1 (de) 1999-06-10
TW218847B (fi) 1994-01-11
HU211636A9 (en) 1995-12-28
HU217806B (hu) 2000-04-28
CA2105466A1 (en) 1993-07-08
KR100290222B1 (ko) 2001-09-17
MX9207605A (es) 1993-08-01
DK0574571T3 (da) 1999-11-01
HUT74578A (en) 1997-01-28
WO1993013804A1 (en) 1993-07-22
HU9302517D0 (en) 1993-12-28
EP0574571B1 (en) 1999-05-06
NZ246577A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
FI933853A (fi) Farmaceutiska kompositioner, som innehaoller antracyklingslykosider kopplade till ett polymerderivat, och foerfarande foer deras framstaellning
SE8504945D0 (sv) Pharmaceutical compositions containing anthracycline glycosides
NO952151D0 (no) Injiserbare, taxanderivat-baserte preparater
MX9203072A (es) Asialoglucoproteina-agente conjugado medicinal.
MA22885A1 (fr) Nouveaux composes actifs.
EA199800938A1 (ru) Композиции, содержащие антигрибковый агент и ацетатный буфер
RU93055778A (ru) Фармацевтические композиции, содержащие антрациклиновые гликозиды, связанные с полимерным производным, и способ их получения
SE8702188D0 (sv) Pharmaceutical compositions
GB1546027A (en) Stabilised thymosin fraction and a method for the preparation of same
SE8703999D0 (sv) Antracyklinglykosider med antitumor effekt, framstellning, mellanprodukter, kompositioner och anordning
DE3752368D1 (de) Doxorubicin enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs
MY110974A (en) Anthracycline conjugates, their preparation and their use as antitumor agents
CA2504963A1 (en) Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer
AU545885B2 (en) Oral absorption of glycosidic antibiotics
ES2006488A6 (es) Un procedimiento para la preparacion de un glicosido de antraciclina.
SE8300324D0 (sv) Daunorubicin och doxorubicin-analoger, deras framstellning och anvendning
AR031508A1 (es) Compuesto polisacarido con actividad inmunoestimulante
BG100647A (en) Perenteral medicamentous form based on avremectine and ivermectine

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.